Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells

Tong Cheng, Wei Cao, Rong Wen, Roy H. Steinberg, Matthew M. LaVail

Research output: Contribution to journalArticle

200 Citations (Scopus)

Abstract

PURPOSE. To investigate the induction of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) gene expression by prostaglandin E2 (PGE2) in cultured rat Muller cells and to study the mechanism of the induction. METHODS. Muller cells were obtained from neonatal Sprague-Dawley rat retinas and cultured in essential modified Eagle's medium supplemented with 10% fetal calf serum for up to four passages. Cells were treated with PGE2, protein kinase A (PKA) inhibitors H-89 or SQ 22536, protein kinase C (PKC) inhibitors calphostin C or GF 109203X, PKC activator phorbol 12-myristate 13-acetate (PMA), or the PKA activator forskolin. Northern blot analysis was performed to determine the levels of VEGF and bFGF mRNA. RESULTS. PGE2 induced VEGF and bFGF mRNA expression in a dose- and time-dependent manner. VEGF and bFGF mRNA reached peaks of 2- and 3.5-fold at 10 μM PGE2. No further increases were observed at 100 μM PGE2. When treated with 10 μM PGE2, the increases in VEGF and bFGF mRNA reached maximum by 2 hours, then slowly declined toward the control level within 24 hours of PGE2 treatment. The inductions of VEGF and bFGF mRNA expression by PGE2 were blocked by the specific PKA inhibitors H-89 (30 μM) or SQ 22536 (500 μM, 1000 μM). Forskolin (10 μM), a cyclic adenosine monophosphate activator, also stimulated VEGF and bFGF mRNA expression. However, the effects of forskolin and PGE2 on VEGF gene expression were not additive, whereas forskolin enhanced the effect of PGE2 on bFGF mRNA expression. The specific PKC inhibitors, GF 109203X (2 μM) and calphostin C (1 μM), did not inhibit PGE2-induced VEGF gene expression, whereas PGE2-induced bFGF expression was blocked by the PKC inhibitor GF 109203X. In addition, downregulation of PKC by PMA (0.8 μM) treatment did not block the induction of VEGF gene expression, whereas it did inhibit the induction of bFGF mRNA expression. CONCLUSIONS. These results indicate that PGE2, stimulates VEGF and bFGF mRNA expression in cultured rat Muller cells. The induction of VEGF seems to occur through activation of the PKA pathway, whereas that of bFGF occurs through PKA and PKC activation. These findings raise the possibility that endogenous PGE2 stimulates VEGF and bFGF mRNA expression in Muller cells in vivo under conditions in which PGE2 production is increased, such as in injury.

Original languageEnglish
Pages (from-to)581-591
Number of pages11
JournalInvestigative Ophthalmology and Visual Science
Volume39
Issue number3
StatePublished - Mar 1 1998
Externally publishedYes

Fingerprint

Ependymoglial Cells
Fibroblast Growth Factor 2
Dinoprostone
Vascular Endothelial Growth Factor A
Messenger RNA
Protein Kinase C
Protein Kinase Inhibitors
Cyclic AMP-Dependent Protein Kinases
Colforsin
Protein C Inhibitor
Gene Expression
Acetates
Eagles

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells. / Cheng, Tong; Cao, Wei; Wen, Rong; Steinberg, Roy H.; LaVail, Matthew M.

In: Investigative Ophthalmology and Visual Science, Vol. 39, No. 3, 01.03.1998, p. 581-591.

Research output: Contribution to journalArticle

@article{45b7d5f4e04040fdb5c4faec23e52dd1,
title = "Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells",
abstract = "PURPOSE. To investigate the induction of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) gene expression by prostaglandin E2 (PGE2) in cultured rat Muller cells and to study the mechanism of the induction. METHODS. Muller cells were obtained from neonatal Sprague-Dawley rat retinas and cultured in essential modified Eagle's medium supplemented with 10{\%} fetal calf serum for up to four passages. Cells were treated with PGE2, protein kinase A (PKA) inhibitors H-89 or SQ 22536, protein kinase C (PKC) inhibitors calphostin C or GF 109203X, PKC activator phorbol 12-myristate 13-acetate (PMA), or the PKA activator forskolin. Northern blot analysis was performed to determine the levels of VEGF and bFGF mRNA. RESULTS. PGE2 induced VEGF and bFGF mRNA expression in a dose- and time-dependent manner. VEGF and bFGF mRNA reached peaks of 2- and 3.5-fold at 10 μM PGE2. No further increases were observed at 100 μM PGE2. When treated with 10 μM PGE2, the increases in VEGF and bFGF mRNA reached maximum by 2 hours, then slowly declined toward the control level within 24 hours of PGE2 treatment. The inductions of VEGF and bFGF mRNA expression by PGE2 were blocked by the specific PKA inhibitors H-89 (30 μM) or SQ 22536 (500 μM, 1000 μM). Forskolin (10 μM), a cyclic adenosine monophosphate activator, also stimulated VEGF and bFGF mRNA expression. However, the effects of forskolin and PGE2 on VEGF gene expression were not additive, whereas forskolin enhanced the effect of PGE2 on bFGF mRNA expression. The specific PKC inhibitors, GF 109203X (2 μM) and calphostin C (1 μM), did not inhibit PGE2-induced VEGF gene expression, whereas PGE2-induced bFGF expression was blocked by the PKC inhibitor GF 109203X. In addition, downregulation of PKC by PMA (0.8 μM) treatment did not block the induction of VEGF gene expression, whereas it did inhibit the induction of bFGF mRNA expression. CONCLUSIONS. These results indicate that PGE2, stimulates VEGF and bFGF mRNA expression in cultured rat Muller cells. The induction of VEGF seems to occur through activation of the PKA pathway, whereas that of bFGF occurs through PKA and PKC activation. These findings raise the possibility that endogenous PGE2 stimulates VEGF and bFGF mRNA expression in Muller cells in vivo under conditions in which PGE2 production is increased, such as in injury.",
author = "Tong Cheng and Wei Cao and Rong Wen and Steinberg, {Roy H.} and LaVail, {Matthew M.}",
year = "1998",
month = "3",
day = "1",
language = "English",
volume = "39",
pages = "581--591",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "3",

}

TY - JOUR

T1 - Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells

AU - Cheng, Tong

AU - Cao, Wei

AU - Wen, Rong

AU - Steinberg, Roy H.

AU - LaVail, Matthew M.

PY - 1998/3/1

Y1 - 1998/3/1

N2 - PURPOSE. To investigate the induction of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) gene expression by prostaglandin E2 (PGE2) in cultured rat Muller cells and to study the mechanism of the induction. METHODS. Muller cells were obtained from neonatal Sprague-Dawley rat retinas and cultured in essential modified Eagle's medium supplemented with 10% fetal calf serum for up to four passages. Cells were treated with PGE2, protein kinase A (PKA) inhibitors H-89 or SQ 22536, protein kinase C (PKC) inhibitors calphostin C or GF 109203X, PKC activator phorbol 12-myristate 13-acetate (PMA), or the PKA activator forskolin. Northern blot analysis was performed to determine the levels of VEGF and bFGF mRNA. RESULTS. PGE2 induced VEGF and bFGF mRNA expression in a dose- and time-dependent manner. VEGF and bFGF mRNA reached peaks of 2- and 3.5-fold at 10 μM PGE2. No further increases were observed at 100 μM PGE2. When treated with 10 μM PGE2, the increases in VEGF and bFGF mRNA reached maximum by 2 hours, then slowly declined toward the control level within 24 hours of PGE2 treatment. The inductions of VEGF and bFGF mRNA expression by PGE2 were blocked by the specific PKA inhibitors H-89 (30 μM) or SQ 22536 (500 μM, 1000 μM). Forskolin (10 μM), a cyclic adenosine monophosphate activator, also stimulated VEGF and bFGF mRNA expression. However, the effects of forskolin and PGE2 on VEGF gene expression were not additive, whereas forskolin enhanced the effect of PGE2 on bFGF mRNA expression. The specific PKC inhibitors, GF 109203X (2 μM) and calphostin C (1 μM), did not inhibit PGE2-induced VEGF gene expression, whereas PGE2-induced bFGF expression was blocked by the PKC inhibitor GF 109203X. In addition, downregulation of PKC by PMA (0.8 μM) treatment did not block the induction of VEGF gene expression, whereas it did inhibit the induction of bFGF mRNA expression. CONCLUSIONS. These results indicate that PGE2, stimulates VEGF and bFGF mRNA expression in cultured rat Muller cells. The induction of VEGF seems to occur through activation of the PKA pathway, whereas that of bFGF occurs through PKA and PKC activation. These findings raise the possibility that endogenous PGE2 stimulates VEGF and bFGF mRNA expression in Muller cells in vivo under conditions in which PGE2 production is increased, such as in injury.

AB - PURPOSE. To investigate the induction of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) gene expression by prostaglandin E2 (PGE2) in cultured rat Muller cells and to study the mechanism of the induction. METHODS. Muller cells were obtained from neonatal Sprague-Dawley rat retinas and cultured in essential modified Eagle's medium supplemented with 10% fetal calf serum for up to four passages. Cells were treated with PGE2, protein kinase A (PKA) inhibitors H-89 or SQ 22536, protein kinase C (PKC) inhibitors calphostin C or GF 109203X, PKC activator phorbol 12-myristate 13-acetate (PMA), or the PKA activator forskolin. Northern blot analysis was performed to determine the levels of VEGF and bFGF mRNA. RESULTS. PGE2 induced VEGF and bFGF mRNA expression in a dose- and time-dependent manner. VEGF and bFGF mRNA reached peaks of 2- and 3.5-fold at 10 μM PGE2. No further increases were observed at 100 μM PGE2. When treated with 10 μM PGE2, the increases in VEGF and bFGF mRNA reached maximum by 2 hours, then slowly declined toward the control level within 24 hours of PGE2 treatment. The inductions of VEGF and bFGF mRNA expression by PGE2 were blocked by the specific PKA inhibitors H-89 (30 μM) or SQ 22536 (500 μM, 1000 μM). Forskolin (10 μM), a cyclic adenosine monophosphate activator, also stimulated VEGF and bFGF mRNA expression. However, the effects of forskolin and PGE2 on VEGF gene expression were not additive, whereas forskolin enhanced the effect of PGE2 on bFGF mRNA expression. The specific PKC inhibitors, GF 109203X (2 μM) and calphostin C (1 μM), did not inhibit PGE2-induced VEGF gene expression, whereas PGE2-induced bFGF expression was blocked by the PKC inhibitor GF 109203X. In addition, downregulation of PKC by PMA (0.8 μM) treatment did not block the induction of VEGF gene expression, whereas it did inhibit the induction of bFGF mRNA expression. CONCLUSIONS. These results indicate that PGE2, stimulates VEGF and bFGF mRNA expression in cultured rat Muller cells. The induction of VEGF seems to occur through activation of the PKA pathway, whereas that of bFGF occurs through PKA and PKC activation. These findings raise the possibility that endogenous PGE2 stimulates VEGF and bFGF mRNA expression in Muller cells in vivo under conditions in which PGE2 production is increased, such as in injury.

UR - http://www.scopus.com/inward/record.url?scp=0031594643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031594643&partnerID=8YFLogxK

M3 - Article

C2 - 9501870

AN - SCOPUS:0031594643

VL - 39

SP - 581

EP - 591

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 3

ER -